Spectrum Pharmaceuticals buy krebskrebs
Start price
23.08.21
/
50%
€2.01
Target price
23.08.22
€3.00
Performance (%)
-34.26%
End price
24.08.22
€1.32
Summary
This prediction ended on 24.08.22 with a price of €1.32. The BUY prediction by krebskrebs for Spectrum Pharmaceuticals performed very badly with a performance of -34.26%. krebskrebs has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Spectrum Pharmaceuticals | - | - | - | - |
| iShares Core DAX® | 2,99 % | 3,22 % | 4,27 % | 53,70 % |
| iShares Nasdaq 100 | -1,58 % | -3,17 % | 24,75 % | 76,70 % |
| iShares Nikkei 225® | -2,25 % | -9,92 % | 43,52 % | 60,79 % |
| iShares S&P 500 | -0,01 % | 1,64 % | 20,97 % | 62,81 % |
Comments by krebskrebs for this prediction
In the thread Spectrum Pharmaceuticals diskutieren
In the thread Trading Spectrum Pharmaceuticals
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten